MICHELLE BRAUN: Open Payments
NPI 1356317614 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,659 in 57 payments from 14 companies in 2025. Trend: 2023 $636 · 2024 $1,254 · 2025 $1,659
Food & beverage: $1,559Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $437 |
| Janssen Biotech, Inc. | 7 | $333 |
| Amgen Inc. | 12 | $240 |
| Novartis Pharmaceuticals Corporation | 4 | $124 |
| Bioventus LLC | 3 | $115 |
| AstraZeneca Pharmaceuticals LP | 2 | $99 |
| Organon LLC | 3 | $70 |
| PFIZER INC. | 2 | $51 |
| Fresenius Kabi USA, LLC | 2 | $49 |
| UCB, Inc. | 2 | $42 |
Products named: TREMFYA, SKYRIZI, KRYSTEXXA, GELSYN-3, RINVOQ, SAPHNELO, COSENTYX, OCTAGAM IMMUNE GLOBULIN (HUMAN).
Industry payments across MD — which companies pay providers there.
